6-(azepan-1-yl)-1-methyl-N-pyridin-2-ylpyrazolo[5,4-b]pyridine-3-carboxamide;6-(azepan-1-yl)-1-methyl-N-pyridin-3-ylpyrazolo[5,4-b]pyridine-3-carboxamide;2,4-difluoro-3-methyl-N-(1-methyl-6-pyrrolidin-1-ylpyrazolo[5,4-b]pyridin-3-yl)benzamide;methane;N-[1-[(4-methylphenyl)methyl]-6-pyrrolidin-1-ylpyrazolo[5,4-b]pyridin-3-yl]oxane-4-carboxamide;tetrakis(2,2,2-trifluoroacetic acid)
C91H104F14N22O13 — CID 158218499
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-(azepan-1-yl)-1-methyl-N-pyridin-2-ylpyrazolo[5,4-b]pyridine-3-carboxamide;6-(azepan-1-yl)-1-methyl-N-pyridin-3-ylpyrazolo[5,4-b]pyridine-3-carboxamide;2,4-difluoro-3-methyl-N-(1-methyl-6-pyrrolidin-1-ylpyrazolo[5,4-b]pyridin-3-yl)benzamide;methane;N-[1-[(4-methylphenyl)methyl]-6-pyrrolidin-1-ylpyrazolo[5,4-b]pyridin-3-yl]oxane-4-carboxamide;tetrakis(2,2,2-trifluoroacetic acid)
6-(azepan-1-yl)-1-methyl-N-pyridin-2-ylpyrazolo[5,4-b]pyridine-3-carboxamide;6-(azepan-1-yl)-1-methyl-N-pyridin-3-ylpyrazolo[5,4-b]pyridine-3-carboxamide;2,4-difluoro-3-methyl-N-(1-methyl-6-pyrrolidin-1-ylpyrazolo[5,4-b]pyridin-3-yl)benzamide;methane;N-[1-[(4-methylphenyl)methyl]-6-pyrrolidin-1-ylpyrazolo[5,4-b]pyridin-3-yl]oxane-4-carboxamide;tetrakis(2,2,2-trifluoroacetic acid) (PubChem CID 158218499) has the molecular formula C91H104F14N22O13 and a molecular weight of 1979.95 g/mol. Its IUPAC name is 6-(azepan-1-yl)-1-methyl-N-pyridin-2-ylpyrazolo[5,4-b]pyridine-3-carboxamide;6-(azepan-1-yl)-1-methyl-N-pyridin-3-ylpyrazolo[5,4-b]pyridine-3-carboxamide;2,4-difluoro-3-methyl-N-(1-methyl-6-pyrrolidin-1-ylpyrazolo[5,4-b]pyridin-3-yl)benzamide;methane;N-[1-[(4-methylphenyl)methyl]-6-pyrrolidin-1-ylpyrazolo[5,4-b]pyridin-3-yl]oxane-4-carboxamide;tetrakis(2,2,2-trifluoroacetic acid).
Molecular Properties
| Compound Name | 6-(azepan-1-yl)-1-methyl-N-pyridin-2-ylpyrazolo[5,4-b]pyridine-3-carboxamide;6-(azepan-1-yl)-1-methyl-N-pyridin-3-ylpyrazolo[5,4-b]pyridine-3-carboxamide;2,4-difluoro-3-methyl-N-(1-methyl-6-pyrrolidin-1-ylpyrazolo[5,4-b]pyridin-3-yl)benzamide;methane;N-[1-[(4-methylphenyl)methyl]-6-pyrrolidin-1-ylpyrazolo[5,4-b]pyridin-3-yl]oxane-4-carboxamide;tetrakis(2,2,2-trifluoroacetic acid) |
|---|---|
| PubChem CID | 158218499 |
| Molecular Formula | C91H104F14N22O13 |
| Molecular Weight | 1979.95 g/mol |
| Exact Mass | 1978.79 |
| IUPAC Name | 6-(azepan-1-yl)-1-methyl-N-pyridin-2-ylpyrazolo[5,4-b]pyridine-3-carboxamide;6-(azepan-1-yl)-1-methyl-N-pyridin-3-ylpyrazolo[5,4-b]pyridine-3-carboxamide;2,4-difluoro-3-methyl-N-(1-methyl-6-pyrrolidin-1-ylpyrazolo[5,4-b]pyridin-3-yl)benzamide;methane;N-[1-[(4-methylphenyl)methyl]-6-pyrrolidin-1-ylpyrazolo[5,4-b]pyridin-3-yl]oxane-4-carboxamide;tetrakis(2,2,2-trifluoroacetic acid) |
| SMILES | C.C.Cc1c(F)ccc(C(=O)Nc2nn(C)c3nc(N4CCCC4)ccc23)c1F.Cc1ccc(Cn2nc(NC(=O)C3CCOCC3)c3ccc(N4CCCC4)nc32)cc1.Cn1nc(C(=O)Nc2ccccn2)c2ccc(N3CCCCCC3)nc21.Cn1nc(C(=O)Nc2cccnc2)c2ccc(N3CCCCCC3)nc21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F |
| InChI | InChI=1S/C24H29N5O2.C19H19F2N5O.2C19H22N6O.4C2HF3O2.2CH4/c1-17-4-6-18(7-5-17)16-29-23-20(8-9-21(25-23)28-12-2-3-13-28)22(27-29)26-24(30)19-10-14-31-15-11-19;1-11-14(20)7-5-12(16(11)21)19(27)23-17-13-6-8-15(26-9-3-4-10-26)22-18(13)25(2)24-17;1-24-18-14(9-10-16(22-18)25-12-6-2-3-7-13-25)17(23-24)19(26)21-15-8-4-5-11-20-15;1-24-18-15(8-9-16(22-18)25-11-4-2-3-5-12-25)17(23-24)19(26)21-14-7-6-10-20-13-14;4*3-2(4,5)1(6)7;;/h4-9,19H,2-3,10-16H2,1H3,(H,26,27,30);5-8H,3-4,9-10H2,1-2H3,(H,23,24,27);4-5,8-11H,2-3,6-7,12-13H2,1H3,(H,20,21,26);6-10,13H,2-5,11-12H2,1H3,(H,21,26);4*(H,6,7);2*1H4 |
| InChIKey | CDZVURCETSNAHO-UHFFFAOYSA-N |
| XLogP | 16.96 |
| TPSA | 436.41 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 27 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 140 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1979.95 |
| LogP ≤ 5 | 16.96 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 27 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158218499 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.